Rationale for treating primary Sjögren’s syndrome patients with an anti-CD6 monoclonal antibody (Itolizumab)
暂无分享,去创建一个
J. Pers | V. Devauchelle | A. Saraux | E. Montero | C. Dantec | Yves Renaudineau | T. Fali | Ruby Alonso
暂无分享,去创建一个
J. Pers | V. Devauchelle | A. Saraux | E. Montero | C. Dantec | Yves Renaudineau | T. Fali | Ruby Alonso